Key result
Sensitive troponin assays for the diagnosis of myocardial infarction present both advantages and limitations in clinical application, as discussed in this editorial.
This editorial discusses the clinical application, advantages, and limitations of sensitive troponin assays for diagnosing myocardial infarction.
Despite the pervasive measurement of cardiac troponin for the diagnosis of myocardial infarction, the continued evolution of assays and guidelines for their application has created uncertainty among many practitioners regarding the use of cutoff values for clinical interpretation. As such, many clinicians may not welcome more sensitive assays for troponin. Nevertheless, professional societies have advocated for improved analytic performance of commercial assays, resulting in a current generation of widely used troponin assays that are more sensitive than their predecessors. In this issue of the Journal, important studies by Keller et al.1 and Reichlin et al.2 reveal the advantages and limitations . . .
No takes yet. Share an insight, caveat, or question.
David A. Morrow (2009) conducted an editorial in Myocardial infarction. Sensitive troponin assays was evaluated. Sensitive troponin assays for the diagnosis of myocardial infarction present both advantages and limitations in clinical application, as discussed in this editorial.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: